Effects of NT-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: a placebo-controlled, randomized trial

OBJECTIVES: To evaluate the safety, pharmacokinetics, and preliminary efficacy of NT-814, a dual neurokinin 1,3 antagonist, in postmenopausal women with vasomotor symptoms (hot flashes). METHODS: We completed a double-blind, randomized, placebo-controlled trial in three US clinical research units in...

Descripción completa

Detalles Bibliográficos
Autores principales: Trower, Mike, Anderson, Richard A., Ballantyne, Elizabeth, Joffe, Hadine, Kerr, Mary, Pawsey, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott-Raven Publishers 2020
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188053/
https://www.ncbi.nlm.nih.gov/pubmed/32068688
http://dx.doi.org/10.1097/GME.0000000000001500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188053/
https://www.ncbi.nlm.nih.gov/pubmed/32068688
http://dx.doi.org/10.1097/GME.0000000000001500

Ejemplares similares